Phreesia Achieves Oracle Validated Integration with Oracle Health EHR Expertise for Delivering Proven, Repeatable Integration

Phreesia announced that it has achieved Oracle Validated Integration with Oracle Health Electronic Health Record (EHR) Expertise for its integration of the Phreesia platform.

VALANX Biotech and Fina Biosolutions Introduce ClickCRM for Rapid Conjugate Vaccine Development

VALANX Biotech (VALANX) and Fina Biosolutions LLC (FinaBio) today announced the signing of a joint IP and licensing agreement. The companies will launch ClickCRM™, a ready-to-conjugate version of CRM197, an antigenic carrier protein used for making conjugate vaccines. The new product enables the rapid, high-efficiency conjugation of carrier proteins to polysaccharide antigens for the generation of conjugate vaccines.

Quris-AI Acquires Nortis

Today, Quris-AI announced the acquisition of Nortis. Nortis' high-quality microphysiology systems (MPS) database and ability to accurately mimic human biology provided a unique value proposition, perfectly aligning with Quris-AI's mission to improve drug safety prediction. Nortis’s Kidney-on-Chip models, which set new standards for in-vitro drug testing and personalized medicine, will be combined with Quris-AI’s advanced machine learning models and patented patient-on-chip system that can predict a real human body’s reaction to drugs and eliminate potentially harmful drug candidates earlier in the drug development process.

Coronado Research Limited announce appointment of Professor Jennifer Visser-Rogers as Chief Scientific Officer

Coronado Research announced today that Professor Jennifer Visser-Rogers has been appointed as Chief Scientific Officer.

Takara Bio Europe Expands Existing Gothenburg Site to Offer Custom Enzyme Manufacturing

Takara Bio Europe has announced the expansion of its Gothenburg facility, with the addition of a custom manufacturing lab. This new facility now offers a comprehensive array of customised molecular biology products, including PCR and qPCR enzymes, servicing the molecular biology needs of academic researchers, diagnostic labs, and biotech companies across EMEA, producing up to 600,000 reactions per week. With these expanded capabilities, customers can expect faster deliveries, personalised service, and real-time access to technical expertise, ensuring projects move forward efficiently while supporting sustainability goals through reduced carbon emissions.

CluePoints Appoints Richard Young as Chief Strategy Officer

RBQM innovator CluePoints has today announced that Richard Young has been appointed as its new Chief Strategy Officer. With 30 years of experience in clinical data management, Richard is an expert in his field.

Sapio Sciences Adds Electronic Batch Record Functionality to Unified GMP LIMS Solution

Sapio Sciences today announced the addition of new Electronic Batch Record (EBR) functionality to Sapio GMP (Good Manufacturing Practice) LIMS. Designed for laboratories that must comply with GMP, 21 CFR 11, and EU Annex 11 standards, the Sapio GMP LIMS offers unparalleled flexibility to meet compliance standards in biotechnology, pharmaceuticals, clinical research and diagnostics, food and beverage, chemicals, and environmental testing.

CluePoints Wins Growth Award at BVA Private Equity Awards

CluePoints, provider of leading statistical and AI-driven software solutions, has been recognized for its impressive growth at the BVA Private Equity Awards.

Biopharma PEG Provides Advanced PEG Solutions for Drug Development

Biopharma PEG has launched a range of polyethylene glycol (PEG) products for PEGylation, improving drug efficacy. With over 40 approved PEGylated drugs, interest in monodispersed PEGs is growing, as seen with Movantik. Biopharma PEG is dedicated to supporting PEGylated drug development.

DNAnexus Strengthens Leadership Team to Drive Ongoing Product Innovation and Commercial Growth

DNAnexus announced the appointment of Nupura Kolwalkar as chief product officer and Bill Madigan as chief commercial officer.

Ellison Institute of Technology Los Angeles Accelerates Cancer Research with Sapio LIMS

Sapio Sciences, the science-aware™ lab informatics platform, today announced that the Ellison Institute of Technology Los Angeles (EIT Los Angeles), a leading interdisciplinary research center focused on cancer and global health, has successfully deployed Sapio Sciences' Laboratory Information Management System (LIMS) to streamline its complex research operations and accelerate scientific discovery.

Optibrium Demonstrates Superior Molecular Docking Method for Small Molecules and Macrocycles

Optibrium, a leading developer of software and AI solutions for molecular design today announced the publication of a peer-reviewed study in the Journal of Computer-Aided Molecular Design, ‘Structure-Based Pose Prediction: Non-cognate Docking Extended to Macrocylic Ligands’. The paper demonstrates that Surflex-Dock can accurately predict the binding conformation and orientation (pose) of unknown (non-cognate) ligands, including macrocycles.

KLAS Research Recognizes Proscia For Improving Patient Outcomes

Proscia was named to KLAS Research’s 2024 Emerging Solutions Top 20 list of technologies best positioned to impact the Quadruple Aim of Healthcare. Its Concentriq software platform was selected by healthcare leaders across the United States for improving patient outcomes. Awardees were celebrated at the HLTH USA event in Las Vegas, Nevada.

Inizio Medical Appoints Patrick Giordani as SVP, AI Solutions Architect, Underpinning Commitment to Expanding AI Capabilities and Accelerating Innovation

Seer Showcases Scalable Proteomic Advancements Impacting Alzheimer’s, Population Health, and Xenotransplantation at HUPO 2024

Seer’s Proteograph™ Product Suite reveals new insights into Alzheimer’s pathways, drives population-scale plasma analysis, and captures immune dynamics in xenotransplantation—with additional breakthrough research from collaborators advancing proteomic discovery at scale

Phenomix Sciences and InformedDNA Partner to Advance Genetics-Driven Obesity Care

Launching at HLTH 2024, the groundbreaking partnership offers payers, health systems, employers, and life science organizations access to personalized obesity care and treatment planning based on a patient’s DNA.

DNA Script Appoints Marc Montserrat as CEO to Drive Long-Term Commercial Growth for Groundbreaking Enzymatic DNA Synthesis Platform

DNA Script announces Marc Montserrat's appointment as CEO.

Firstsource positioned a ‘Leader’ in Everest Group's Healthcare Payer Business Process as a Service Solutions PEAK Matrix® Assessment 2024

Healthcasts Names Max Baumer Chief Operating Officer & Chief Financial Officer

Healthcasts, the leading online community for healthcare professional consultation and real-world experience, today announced the appointment of Max Baumer, CPA, as Chief Operating Officer and Chief Financial Officer. Baumer has spent over a decade overseeing finance and operations for companies experiencing exceptional growth including large hospital systems and healthcare staffing companies, making him uniquely positioned to bridge financial and operational duties in his role at Healthcasts.

90% of Hospital and Health System Revenue Cycle Leaders Believe GenAI Will Impact Medical Coding Operations